Brewin Dolphin LTD Gelesis Holdings, Inc. Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

A detailed history of Brewin Dolphin LTD transactions in Gelesis Holdings, Inc. stock. As of the latest transaction made, Brewin Dolphin LTD holds 4,700 shares of GLS stock, worth $94. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,700
Previous 4,700 -0.0%
Holding current value
$94
Previous $21,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Nov 14, 2022
BUY
N/A
4,700 New
4,700 $21,000

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About GELESIS HOLDINGS, INC.

GLS Quotes by TradingView
  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email